Cellular Uptake of Misonidazole and Analogues with Acidic or Basic Functions
Authors:
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 47 (6) , 629-643
Abstract
Average intracellular concentrations of five radiosensitizers in hamster fibroblast-like V79-379A cells in vitro were measured by high performance liquid chromatography, varying the extracellular pH (pHe) and estimating the apparent intracellular pH from the distribution of 5,5-dimethyloxazolidine-2,4-dione. The intracellular: extracellular concentration ratio for the 2-nitroimidazole, misonidazole was constant at about 0.7 for pHe = 6.6-7.6, whereas the weak base, Ro 03-8799 (1-(2-nitro-1-imidazolyl)-3-N-piperidino-2-propanol) was concentrated intracellularly at pHe = 7.3-7.4 by a factor of 3.3, the factor increasing from about 0.8 at pHe = 6.0, to 7.5 at pHe = 7.85. The weak acid, azomycin (2-nitroimidazole) showed approximately constant uptake (factor 1.1) between pHe = 6.0-7.0, decreasing to 0.8 at pHe = 7.3 and 0.4 at pHe = 7.8. Measurements of intracellular uptake of Ro 31-0052 (the more hydrophilic and less basic 3'-hydroxypiperidino analogue of Ro 03-8799) and of Ro 31-0258 (3-(2-nitro-1-imidazolyl)propionic acid, a stronger acid than azomycin) were made for comparison. The results were compared with theoretical calculations of pH-induced concentration gradients; the time dependence of the uptake of the bases is not at present clearly understood. These measurements of uptake are broadly consistent with the distribution of misonidazole and Ro 03-8799 in human and animal tissues and provide a useful insight into the likely intracellular concentrations in the clinical use of Ro 03-8799 or other basic radiosensitizers. The measurements also resolve the apparent discrepancy in radiosensitizer efficiency for weak bases in vitro and in vivo which has been previously noted.Keywords
This publication has 24 references indexed in Scilit:
- The clinical testing of Ro 03-8799—Pharmacokinetics, toxicology, tissue and tumor concentrationsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- A phase I study of the hypoxic cell radiosensitizer Ro-03-8799International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- Pharmacokinetic studies using multiple administration of RO 03–8799, a 2-nitroimidazole radiosensitizerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- A comparative analysis of extracellular fluid volume of several tissues as determined by six different markersLife Sciences, 1981
- Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblastsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1981
- A serial study of the concentration of misonidazole in human tumors correlated with histologic structureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1981
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1979
- The Proton Electrochemical Gradient in Escherichia coli CellsEuropean Journal of Biochemistry, 1976
- CALCULATION OF INTRACELLULAR pH FROM THE DISTRIBUTION OF 5,5-DIMETHYL-2,4-OXAZOLIDINEDIONE (DMO). APPLICATION TO SKELETAL MUSCLE OF THE DOG*Journal of Clinical Investigation, 1959